DrugDashboards

Paroxetine

Paroxetine · PAROXETINE HYDROCHLORIDE 12.5 mg/1 · Tablet, Film Coated, Extended Release · Oral · Westminster Pharmaceuticals, LLC

NDC 69367-0335-30 · 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price is up 13% over the past year, to $0.4918 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.4918per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.4768per TABweighted avg manufacturer price $0.1933 · Jul 1, 202697% of what pharmacies pay — a deeper discount than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Oct 2021Sep 2026$0.4918
60 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$14.75
#90 count
$44.26

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$6,998
265 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for paroxetine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA213485
TE code
AB
Approval date
Feb 16, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Paroxetine (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.PAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 25 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 37.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Paroxetine — NDC 69367-0335-30," retrieved September 3, 2026, https://drugdashboards.com/drug/69367033530.

Free to cite with attribution — see how the data is put together.